Ramanan Laxminarayan

Director and Senior Fellow

Ramanan Laxminarayan directs the Center for Disease Dynamics, Economics & Policy. He is also a Senior Research Scholar and Lecturer at Princeton University. His research deals with the integration of epidemiological models of infectious diseases and drug resistance into the economic analysis of public health problems. He has worked to improve understanding of drug resistance as a problem of managing a shared global resource.

Laxminarayan has worked with the World Health Organization (WHO) and the World Bank on evaluating malaria treatment policy, vaccination strategies, the economic burden of tuberculosis, and control of non-communicable diseases. He has served on a number of advisory committees at WHO, Centers for Disease Control and Prevention, and the Institute of Medicine. In 2003-04, he served on the National Academy ofScience/Institute of Medicine Committee on the Economics ofAntimalarial Drugs and subsequently helped create the Affordable Medicines Facility for malaria, a novel financing mechanism for antimalarials. His work has been covered in major media outlets including Associated Press, BBC, CNN, the Economist, LA Times, NBC,NPR, Reuters, Science, Wall Street Journal, and National Journal.

 

Publications

22 Jun 2016

How can we model the transmission of Streptococcus pneumoniae for public health and policy, capturing the...

25 May 2016
Many high-income countries have surveillance systems that keep track of antimicrobial resistance (AMR) rates, but very few low- and middle-income countries (LMICs) do. Can networks of private...
9 Mar 2016
Does India’s Integrated Child Development Services (ICDS), which provides daily supplemental nutrition and an array of services such as immunization and health checkups to pregnant women and...
11 Nov 2015

Among rural Indian households who currently do not have access to (or those who do not access) neonatal care, what are the health and economic benefits of scaling up access to a package of home-...

6 Nov 2015

What are some of the unintended consequences of India’s Safe Motherhood Scheme (JSY), one of the largest conditional cash transfer programs for pregnant women in the world? How has the program...

16 Oct 2015

What is the efficacy of antibiotic prophylaxis for surgery and cancer chemotherapy on preventing infections and infection-related deaths in the United States? How would decreased antibiotic...

1 Oct 2015

What existing evidence exists regarding the impact of Rashtriya Swasthya Bima Yojana (RSBY)—a government-run health insurance program for the poor in India? How reliable is the existing...